Gyre Therapeutics, Inc. dividend history

Gyre Therapeutics, Inc.'s dividend was $0.240 a share in fiscal 2022, down NaN% on the year before. That was 1043.8% of net income.

Dividends, buybacks and capital spending

Diluted share count: +4.5%; year over year
R&D spending: 18.6%; of revenue
Days sales outstanding: 85 days; receivables vs revenue

Dividends by fiscal year

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Gyre Therapeutics, Inc.: dividends by fiscal year, annual
Fiscal year	2009Dec 2009	2010Dec 2010	2011Dec 2011	2012Dec 2012	2013Dec 2013	2014Dec 2014	2017Dec 2017	2018Dec 2018	2020Dec 2020	2021Dec 2021	2022Dec 2022	2023Dec 2023	2024Dec 2024	2025Dec 2025	LTMJun 2026
Dividend per share	—	—	—	—	—	—	—	—	—	—	$0.240	—	—	—	—
Dividends paid	—	—	—	—	—	—	—	—	—	—	45	—	—	—	—
Dividends ÷ net income	—	—	—	—	—	—	—	—	—	—	>999%	—	—	—	—

Dividend per share is the amount declared for the fiscal year as stated in the company's filings (including any special dividend), restated for stock splits and checked against the cash dividends paid. Dividends paid and buybacks are cash amounts; the last-twelve-months column can include an extra payment when a quarter-end date moves.

More: Pharmaceuticals stocks compared, Health Care sector, rankings of US companies

Figures from Gyre Therapeutics, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Gyre Therapeutics, Inc.